ANTONIO
MIGUEL MATAS
INVEST DOCT UV JUNIOR
MRC Biostatistics Unit
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de MRC Biostatistics Unit (1)
2017
-
Silencing of foxp3 enhances the antitumor efficacy of GM-CSf genetically modified tumor cell vaccine against B16 melanoma
OncoTargets and Therapy, Vol. 10, pp. 503-514